CGM for Management of Type 2 Diabetes in Pregnancy
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 564 participants.
Also called NCT06628453
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 564 participants
- Sponsor
- Registry
-
NCT06628453
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06628453. Randomized; no masking; primary purpose treatment. Start 2025-04-08 (actual); primary completion 2029-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CGM for Management of Type 2 Diabetes in Pregnancy
- Acronym
- CGM2
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Condition
- Pregnancy
- Intervention (Device)
- CGM
- Lead sponsor
- University of Alabama at Birmingham
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Record details
- Record id
cardio:ct-nct06628453- Content hash
fd50958ecaf04d69a05cba915228f3136686f6ed2ecc4de7c1fba4b0ed00fb2f